
RVXCF
Healthcare · Biotechnology · $17.2M market cap
$0.0500-0.01 (-16.7%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Oct 31, 2019
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 13, 2026 | After the close | — | -0.02 | — |
| May 14, 2026 | After the close | — | -0.01 | — |
| Mar 31, 2026 | After the close | — | -0.00 | — |
| Nov 13, 2025 | After the close | — | -0.00 | — |
| Aug 14, 2025 | Before the open | — | -0.01 | — |
| May 10, 2025 | After the close | — | -0.02 | — |
| Nov 7, 2024 | After the close | — | -0.02 | — |
| Aug 9, 2024 | After the close | — | -0.02 | — |
| May 14, 2024 | After the close | — | 0.00 | — |
| Mar 31, 2024 | Time not confirmed | — | 0.00 | — |
| Dec 31, 2023 | Time not confirmed | — | -0.01 | — |
| Sep 30, 2023 | Time not confirmed | — | -0.02 | — |
| Jun 30, 2023 | Time not confirmed | — | -0.01 | — |
| Mar 31, 2023 |
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The…
| Time not confirmed |
| — |
| -0.02 |
| — |
| Dec 31, 2022 | Time not confirmed | — | 0.00 | — |
| Sep 30, 2022 | Time not confirmed | — | -0.01 | — |
| Jun 30, 2022 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2022 | Time not confirmed | — | -0.01 | — |
| Dec 31, 2021 | Time not confirmed | — | -0.07 | — |
| Sep 30, 2021 | Time not confirmed | 0.00 | -0.02 | — |
| Jun 30, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Mar 31, 2021 | Time not confirmed | — | 0.00 | — |
| Dec 14, 2020 | After the close | — | -0.02 | — |
| Oct 2, 2020 | After the close | — | -0.02 | — |
| Jul 31, 2020 | Time not confirmed | — | -0.03 | — |
| Apr 30, 2020 | Time not confirmed | — | 0.04 | — |
| Mar 13, 2020 | After the close | — | 0.04 | — |
| Jan 31, 2020 | Time not confirmed | — | 0.02 | — |
| Dec 16, 2019 | After the close | — | 0.02 | — |
| Oct 31, 2019 | Time not confirmed | -0.10 | -0.02 | +80.0% |
| Sep 16, 2019 | After the close | -0.10 | -0.02 | +80.0% |
| Jul 31, 2019 | Time not confirmed | -0.02 | -0.34 | -1600.0% |
| Jul 29, 2019 | After the close | -0.02 | -0.34 | -1600.0% |
| Apr 30, 2019 | Time not confirmed | -0.03 | -0.07 | -133.3% |
| Mar 15, 2019 | After the close | -0.03 | -0.07 | -133.3% |
| Jan 31, 2019 | Time not confirmed | -0.07 | -0.21 | -200.0% |
| Dec 13, 2018 | After the close | -0.07 | -0.21 | -200.0% |
| Oct 31, 2018 | Time not confirmed | — | -0.21 | — |
| Sep 14, 2018 | After the close | — | -0.21 | — |
| Jul 30, 2018 | After the close | — | -0.28 | — |
| Apr 30, 2018 | Time not confirmed | — | -0.05 | — |
| Mar 16, 2018 | After the close | — | -0.05 | — |
| Jan 31, 2018 | Time not confirmed | — | -0.15 | — |